Soru

Zorluk: ZorDiagnostic Workup and Test Sequencing

A 42-year-old woman is evaluated in the clinic due to an 8-month history of progressively worsening shortness of breath. She initially noticed dyspnea only when climbing stairs, but now experiences it while walking on level ground. She has no significant past medical history, takes no medications, and has never smoked. Vital signs show blood pressure of 118/76 mm Hg, heart rate of 88/min, respiratory rate of 18/min, and oxygen saturation of 96% on room air. Jugular venous pulsation is visible 8 cm above the sternal angle. Chest auscultation reveals clear breath sounds bilaterally. Cardiac examination shows a parasternal heave, a loud pulmonic component of the second heart sound (P 2_2), and a faint holosystolic murmur at the lower left sternal border that augments with inspiration. There is trace lower extremity edema. Initial diagnostic testing reveals the following:

- ECG: Right axis deviation and right ventricular hypertrophy.
- Chest X-ray: Enlarged central pulmonary arteries with clear lung parenchyma.
- Transthoracic echocardiogram: Right ventricular dilation with an estimated right ventricular systolic pressure of 65 mm Hg. Left ventricular size and systolic function are normal. There is no significant mitral or aortic valvular disease.
- Pulmonary function tests: Normal spirometry and lung volumes.
- High-resolution chest CT: No evidence of interstitial lung disease.

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

  1. A
    Computed tomography pulmonary angiography
  2. B
    Overnight polysomnography
  3. Radionuclide ventilation-perfusion scanCevap
  4. D
    Right heart catheterization
  5. E
    Transesophageal echocardiography

Cevap

Radionuclide ventilation-perfusion scan
The correct answer is a radionuclide ventilation-perfusion (V/Q) scan. This patient presents with clinical signs of right heart failure and echocardiographic evidence of severe pulmonary hypertension (PH). The diagnostic workup of PH requires a sequential approach to identify the underlying etiology (Groups 1-5) before proceeding to invasive hemodynamic confirmation. The patient's normal left ventricular function makes Group 2 (left heart disease) unlikely. Normal pulmonary function tests and a clear high-resolution CT scan effectively rule out Group 3 (lung disease). The next crucial step is to differentiate Group 4 (chronic thromboembolic pulmonary hypertension, CTEPH) from Group 1 (pulmonary arterial hypertension). A radionuclide V/Q scan is the recommended screening test for CTEPH because it is highly sensitive for detecting chronic, organized microvascular thrombi.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and initial echocardiogram.
The patient has severe right ventricular volume/pressure overload and an elevated estimated right ventricular systolic pressure (65 mm Hg), indicating pulmonary hypertension (PH). Normal left ventricular function rules out Group 2 (left heart disease) PH.
Establishing the presence of PH and ruling out the most common cause (left heart disease) dictates the subsequent diagnostic pathway.
2
Evaluate the results of the initial lung imaging and pulmonary function tests.
Normal PFTs and a clear high-resolution chest CT effectively rule out Group 3 PH (lung parenchymal disease and chronic hypoxia).
This narrows the differential diagnosis down to Group 1 (Pulmonary Arterial Hypertension) and Group 4 (Chronic Thromboembolic Pulmonary Hypertension).
3
Determine the most appropriate non-invasive test to differentiate Group 1 from Group 4 PH.
A radionuclide ventilation-perfusion (V/Q) scan is selected as the next test.
Guidelines mandate screening all patients with unexplained PH for chronic thromboembolic pulmonary hypertension (CTEPH). V/Q scanning is the preferred modality due to its high sensitivity for chronic microvascular thrombi, outperforming CT pulmonary angiography in this specific chronic setting.

Anahtar Kavram

In the diagnostic algorithm for pulmonary hypertension, after left heart and primary lung diseases are excluded, a radionuclide ventilation-perfusion (V/Q) scan is the most appropriate next step to screen for chronic thromboembolic pulmonary hypertension (CTEPH) prior to invasive confirmation with right heart catheterization.
Tahmini Süre:1m 30s
Bu soruyu puanla